Slashed US funding threatens millions of children: charity chief
A halt to US funding for Gavi, an organisation that vaccinates children in the worlds poorest countries, will leave a dangerous gap threatening the lives of millions, its chief warned on Monday.
"The first impact would be for the most vulnerable children of the world," Gavi chief executive Sania Nishtar told AFP.
She spoke via video link from Washington, during a visit to try to convince US authorities that their 25-year collaboration with the Geneva-based organisation must continue.
The New York Times broke the news last week that President Donald Trump's administration, which has been aggressively slashing foreign aid, aims to cut all funding to Gavi.
That step featured in a 281-page spreadsheet related to a cuts to USAID that was sent to the US Congress.
The decision would impact about 14 percent of Gavi's core budget -- and came just days after the Congress had approved $300 million in funding for the organisation.
"I was very, very surprised," Nishtar said, adding that her organisation still had received no official termination notice from the US government.
The medical doctor and former minister and senator in Pakistan said: "Gavi was supported by the previous Trump administration. We had a very good relationship."
If the cuts go ahead, Nishtar warned it would have devastating effects.
- 'Children will die' -
"Frankly, this is too big a hole to be filled," Nishtar warned, even as Gavi scrambled to find donors to offset the missing US funding.
"Something will have to be cut."
Gavi says it helps vaccinate more than half the world's children against infectious diseases including Covid-19, Ebola, malaria, rabies, polio, cholera, tuberculosis (TB), typhoid and yellow fever.
Since its inception in 2000, Gavi has provided vaccines to more than 1.1 billion children in 78 lower-income countries, "preventing more than 18.8 million future deaths," it says.
Before the US decision, the organisation has a goal of vaccinating 500 million more children between 2026 to 2030.
The US contribution is directly responsible for funding 75 million of those vaccinations, Nishtar said.
Without them, "around 1.3 million children will die from vaccine-preventable diseases".
Beyond Gavi's core immunisation programmes, the funding cut would jeopardise the stockpiling and roll-out of vaccines against outbreaks and in health emergencies, including for Ebola, cholera and mpox.
"The world's ability to protect itself against outbreaks and health emergencies will be compromised," Nishtar said.
- 'More exposed' -
During her Washington visit, the Gavi chief said she aimed to show how effective funding has been so far for her organisation.
For every $1 spent on vaccinations in developing countries where Gavi operates, $21 will be saved this decade in "health care costs, lost wages and lost productivity from illness and death," the vaccine group estimates.
Unlike other organisations facing cuts, Gavi has not received an outsized contribution from Washington towards its budget, Nishtar noted, insisting that the US contribution was proportionate to its share of the global economy.
Other donors were paying their "fair share", while recipient countries also pitch in and are provided with a path to transition away from receiving aid, she said.
Some former recipients, like Indonesia, had even become donors to the programme, she pointed out, voicing hope that such arguments would help sway Washington to decide to stay the course.
Without the US backing, "we will have to make difficult trade-offs", Nishtar warned.
That "will leave us all more exposed".
nl/vog/rmb
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Omada Health IPO signals healthier market, avoids 'down-round' trend
The IPO market is starting to feel healthier. Omada Health, a 14-year-old company providing virtual care for chronic conditions like diabetes and hypertension between office visits, closed its first trading day on Friday at $23 a share, a 21% jump from the IPO price of $19. The IPO valued the company just above $1 billion (excluding employee options), a figure that's nearly identical to Omada's last private valuation of $1 billion set in its previous VC round. The debut is one of the first among recent IPOs that was not a so-called down-round. Many of the latest public listings, including Hinge, ServiceTitan, and Reddit, priced below their private market highs, though have faired well as public companies. For founder and CEO Sean Duffy, the successful public offering validates his decision to start a company that he believed the market desperately needed. In 2011, he dropped out of Harvard Medical School after realizing that chronic illness patients required more continuous support than the existing healthcare system delivered. Before the offering, he owned 4.1% of the company, according to Omada's offering document. Other significant shareholders included Revelation Partners (10.9%), US Venture Partners (9.9%), Andreessen Horowitz (9.6%), and FMR (9.3%). Duffy told TechCrunch that over his 14-year journey as a founder, he had many harrowing moments. "I didn't think our series A was going to come together because we were working on this commercial deal that didn't materialize, and that spooked one investor," he said. "As a young business, something tries to kill you every month," he continued. "And then as the business grows, it turns into like every quarter or six months, year, two years." One of the recent challenges for many digital health businesses is navigating the "collapse" of the market post-COVID boom. Omada steered through the turbulent times by seeking new, rising markets. It recently expanded its offerings to include diet management support for GLP-1 patients.
Yahoo
6 hours ago
- Yahoo
Tampa Police get 300 new lifesaving choking devices from New York-based company
The Brief A company based in New York donated choking rescue devices to the Tampa Police Department. The devices, which are called LifeVac, create a one-way suction to remove lodged food or objects from a choking victim. These devices will be distributed to officers soon. TAMPA, Fla. - A New York-based company donated 300 choking rescue devices to the Tampa Police Department. These devices, called LifeVac, create a one-way suction to remove lodged food or objects from a choking victim. "This is just another tool for us, especially for our youth, to be out there and provide another opportunity to save a life," Tampa Police Chief Lee Bercaw said of the donation. The backstory Last month,a Tampa police officer used back blows to help save a toddler who was choking on a tomato. "That's the reason that we're getting this donation," Bercaw said Friday of the bodycam video. "[LifeVac inventor] Mr. Lih saw that video and said, 'I've got to get that product down here in a generous donation.'" "I knew as a parent, I'd be freaking out. I would be very distressed. So I tried to come up with something really simple. You push it, pull it, and that suction pulls it out," LifeVac President and Creator Arthur Lih said. These devices will be distributed to officers soon. Bercaw told FOX 13 the devices will be placed in patrol cars and will be used in schools and at Police Athletic League youth activities. Dig deeper As shown in LifeVac's online instructional video, the New York-based company said people should first follow choking protocols established by the American Red Cross. That means doing back blows and abdominal thrusts first. And if those actions don't work – or if those actions cannot be completed for whatever reason – then a LifeVac device can come into play. The U.S. Food and Drug Administration (FDA) encourages people to follow established choking rescue protocols by the American Red Cross and the American Heart Association. In an April 2024 update, the FDA said these protocols do not include anti-choking devices: "The safety and effectiveness of anti-choking devices that are being sold over-the-counter have not been established; they are not FDA approved or cleared." Success Stories Just this week, a Georgia police officer used a LifeVac device to save a driver choking on a water bottle cap. Years ago, LifeVac devices were placed in every school in Sarasota County. The Source The information in this story was gathered by FOX 13's Ariel Plasencia.
Yahoo
6 hours ago
- Yahoo
Migratory birds develop antibodies to bird flu, officials say
(WAVY) – Wildlife officials are keeping a close eye on the spread of avian influenza after along the North Carolina coast earlier this year — most of them brown pelicans. The outbreak has since been linked to the H5N1 strain of bird flu, a virus that continues to mutate and occasionally jump to other species, raising concern among experts. Miranda Turner, a wildlife health biologist with the North Carolina Wildlife Resources Commission, said the area is a prime wintering ground for birds — making it easier for disease to spread. 'When you bring a lot of animals together and you have them traveling from different locations, it's a really good way to transmit diseases,' Turner said. In Hampton Roads, bird flu outbreaks aren't new. Lisa Barlow, president of T recalls treating sick and dying Canada geese during a 2021 outbreak on the Lafayette River. 'We dealt with about three to four dozen Canada geese that came in sick and dying,' Barlow said. 'Only six survived the flu, and even those had to be euthanized due to severe neurological symptoms.' Barlow described birds arriving unable to hold their heads up, their beaks caked in mud. Many died within 24 hours. As the virus continues to affect wildlife, it's not just birds at risk. , including seals, cats and even cattle. Experts say it's mutated at least several times since it was first identified. 'I mean, anything that can do that — it's kind of frightening, but amazing,' Barlow said. Despite the concerning spread, health officials emphasize the risk to humans remains low. According to the Centers for Disease Control and Prevention, 70 human cases have been reported nationwide, including one death. Most infections have been among people with repeated exposure to infected animals, such as poultry or dairy farm workers. 'There's really low risk,' Turner said. 'Still, it's a good idea to clean bird feeders regularly and wear gloves or a mask if you handle injured wildlife.' Barlow also urges caution for those who come across sick birds. 'If you do want to help, wear gloves, protect yourself,' she said. 'Common sense goes a long way.' Meanwhile, as migratory birds continue to interact and spread the virus, some are developing natural antibodies, according to Turner. 'They're bouncing back and creating herd immunity,' she said. Last week, the Associated Press reported the in funding meant to support Moderna's development of a bird flu vaccine. The vaccine, which uses mRNA technology similar to the COVID-19 vaccine, had shown early promise in clinical trials. For now, wildlife officials say they expect to see more outbreaks in the years ahead, especially during peak migration periods. 'Because this virus is so common in migratory birds, it is likely that we will continue to see cases here and there every winter,' Turner said. As of right now, there have been no confirmed human cases of H5N1 in Virginia and although the risk remains low for humans, for birds it can be extremely deadly – leading to large die-off events like the ones we saw near Cape Hatteras. 'Unfortunately, this was the first kind of major large scale mortality event… while it looks really bad at that small scale of seeing 300 brown pelicans die – it's not impacting their population as a whole or the species as a whole,' adds Turner. Turner also explains that the surviving pelicans are still there, 'The brown pelicans that did survive that event were still nesting on that island successfully and are doing well. So really, it's a short scale kind of scary looking event, but nothing that raises alarm for biologists in the long term.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
